¼¼°èÀÇ Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀå
Intelligent Asthma Monitoring Devices
»óǰÄÚµå : 1798922
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 210 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,206,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,620,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ¼¼°è ½ÃÀåÀº 2030³â±îÁö 28¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 7¾ï 8,730¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ¼¼°è ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â¿¡ CAGR 23.7%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 28¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¿þ¾î·¯ºí õ½Ä ¸ð´ÏÅ͸µ ±â±â´Â CAGR 20.2%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á±îÁö 5¾ï 8,100¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ½º¸¶Æ® ÈíÀԱ⠺ι®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 26.1%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 2¾ï 1,450¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 30.8%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº 2024³â¿¡ 2¾ï 1,450¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 6¾ï 6,330¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 30.8%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 19.4%¿Í 21.0%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 19.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

Áö´ÉÇü ±â±â°¡ ȯÀÚ¿Í ÀÇ·áÁøÀÇ Ãµ½Ä °ü¸®¸¦ ¾î¶»°Ô º¯È­½Ãų °ÍÀΰ¡?

Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â´Â ÈíÀԱ⠻ç¿ë·®À» ÃßÀûÇϰí È£Èí ÆÐÅÏÀ» ¸ð´ÏÅ͸µÇϸç ȯÀÚ¿Í ÀÓ»óÀÇ¿¡°Ô ½Ç½Ã°£ Çǵå¹éÀ» Á¦°øÇÏ´Â ¿¬°á ½Ã½ºÅÛÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â±â¿¡´Â ½º¸¶Æ® ÈíÀÔ±â, ¿þ¾î·¯ºí ¼¾¼­, µðÁöÅÐ ÆóȰ·®°è, Åõ¾à ¾Ë¸², Áõ»ó ÃßÀû, ȯ°æ ¾Ë¸²À» ÅëÇÕÇÑ ¸ð¹ÙÀÏ °Ç°­ Ç÷§Æû µîÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ±â±âÀÇ µµÀÔÀ¸·Î õ½Ä °ü¸®´Â ÀϽÃÀûÀÎ Ä¡·á¿¡¼­ Áö¼ÓÀûÀÎ µ¥ÀÌÅÍ ±â¹Ý ¸ð´ÏÅ͸µÀ¸·Î º¯È­Çϰí ÀÖ½À´Ï´Ù.

ȯÀÚ´Â ¼øÀÀµµ Çâ»ó, Áõ»ó Á¶Àý °³¼±, Àû½Ã °³ÀÔÀÇ ÇýÅÃÀ» ´©¸± ¼ö ÀÖÀ¸¸ç, ÀÇ·áÁøÀº ÈíÀÔ ±â¼ú, »ç¿ë ºóµµ, Ä¡·á ¹ÝÀÀ¿¡ ´ëÇÑ °´°üÀûÀÎ µ¥ÀÌÅÍ¿¡ Á¢±ÙÇÒ ¼ö ÀÖ°Ô µË´Ï´Ù. Áö´ÉÇü ¸ð´ÏÅ͸µÀº ƯÈ÷ ¼Ò¾Æ, ³ëÀÎ, Á¶ÀýÀÌ ¾î·Á¿î õ½Ä ȯÀÚ¿¡¼­ ÀÀ±Þ½Ç ¹æ¹®À» ÁÙÀÌ°í ¾ÇÈ­¸¦ ¿¹¹æÇÏ´Â µ¥ À¯¿ëÇÕ´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â °³Àκ° ¸ÂÃã Ä¡·á °èȹ°ú Àå±âÀûÀÎ °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

¾î¶² ±â¼ú°ú ±â´ÉÀÌ ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÇ Çõ½ÅÀ» ÁÖµµÇϰí Àִ°¡?

±â¼úÀÇ ¹ßÀüÀº Áö´ÉÇü õ½Ä ±â±â °³¹ßÀÇ Áß½ÉÀÌ µÇ°í ÀÖ½À´Ï´Ù. ºí·çÅõ½º Áö¿ø ÈíÀԱ⠾îÅÂÄ¡¸ÕÆ®¿Í ¿þ¾î·¯ºí È£Èí ¸ð´ÏÅÍ´Â ½Ç½Ã°£ »ç¿ë µ¥ÀÌÅ͸¦ ¼öÁýÇÏ°í ºÐ¼®À» À§ÇØ Å¬¶ó¿ìµå ±â¹Ý Ç÷§ÆûÀ¸·Î Àü¼ÛÇÕ´Ï´Ù. ¸ð¹ÙÀÏ ¾Û°úÀÇ ÅëÇÕÀ» ÅëÇØ ȯÀÚ´Â ÃßÀ̸¦ È®ÀÎÇϰí, ¾Ë¸²À» ¹Þ°í, Áõ»óÀ» º¸°íÇÒ ¼ö ÀÖ½À´Ï´Ù. ²É°¡·ç, ±â¿Â, °ø±âÁú µîÀÇ È¯°æÀû ¿äÀÎÀ» ÃßÀûÇÏ´Â ¼¾¼­¸¦ ³»ÀåÇÏ¿© À§Çè »óȲÀ» »ç¿ëÀÚ¿¡°Ô °æ°íÇÏ´Â ±â±âµµ ÀÖ½À´Ï´Ù.

¸Ó½Å·¯´×°ú ¿¹Ãø ºÐ¼®Àº õ½Ä ¹ßÀÛ ¿¹Ãø°ú ¼øÀÀµµ ÆÐÅÏÀ» ÆÄ¾ÇÇÏ´Â µ¥ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. °ÔÀÓÈ­µÈ ÀÎÅÍÆäÀ̽º¿Í °¡Á· ¸ð´ÏÅ͸µ ±â´ÉÀ» °®Ãá ¼Ò¾Æ ¸ðµ¨Àº ¾î¸° ȯÀÚµéÀÇ Âü¿©µµ¸¦ ³ôÀÌ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. À½¼º ¾È³»¸¦ ÅëÇÑ ÈíÀÔ±â ÄÚĪ, ½º¸¶Æ® Åõ¾à ½Ã½ºÅÛ, ´Ù¾àÁ¦ º´¿ëÀÌ Ãß°¡µÇ¾î »ç¿ë ÆíÀǼºÀÌ Çâ»óµÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, ÀüÀÚÀǹ«±â·Ï°úÀÇ È£È¯¼ºÀ» ÅëÇØ ¿ø°ÝÁø·á ¹× Ä¡·áÀÇ »çÀü Á¶À²µµ ¿ëÀÌÇÕ´Ï´Ù.

¾îµð¿¡¼­ ÀÌ¿ëÀÌ È®´ëµÇ°í ÀÖÀ¸¸ç, ¾î¶² ÀÌÇØ°ü°èÀÚ°¡ µµÀÔÀ» ÁÖµµÇϰí Àִ°¡?

º´¿ø, ¿Ü·¡Áø·á¼Ò, ÀçÅÃÀÇ·á ÇöÀå¿¡¼­ ÀÌ¿ëÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. Áߵ¿¡¼­ ÁßÁõÀÇ Ãµ½Ä, ÀæÀº ÀÔ¿ø, Àϰü¼º ¾ø´Â ¾à¹° »ç¿ë ȯÀÚ´Â Áö´ÉÇü ¸ð´ÏÅ͸µÀÇ ÁÖ¿ä »ç¿ëÀÚÀÔ´Ï´Ù. ÁÖÄ¡ÀÇ, È£Èí±â Àü¹®ÀÇ, ¾Ë·¹¸£±â Àü¹®ÀÇ´Â µ¥ÀÌÅ͸¦ Ȱ¿ëÇØ Àû½Ã¿¡ Ä¡·á °áÁ¤À» ³»¸®°í Ä¡·áÀÇ ÆíÂ÷¸¦ ÁÙÀ̱â À§ÇØ µ¥ÀÌÅ͸¦ Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù. ¼Ò¾Æ õ½Ä ÇÁ·Î±×·¥¿¡¼­´Â ½º¸¶Æ® ±â±â¸¦ Çб³ ±â¹Ý °Ç°­ ÀÌ´Ï¼ÅÆ¼ºê¿¡ ÅëÇÕÇϰí ÀÖ½À´Ï´Ù.

ºÏ¹Ì¿Í À¯·´ÀÇ ÀÇ·á ½Ã½ºÅÛÀº »óȯ Áö¿ø, ¸¸¼ºÁúȯ °ü¸® ÇÁ·¹ÀÓ¿öÅ©, mHealth ÀÎÇÁ¶ó¸¦ ÅëÇØ äÅÃÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀåÀº µµ½Ã Àα¸, ¸ð¹ÙÀÏ ¿¬°á¼º, õ½Ä À¯º´·ü Áõ°¡¸¦ ¹è°æÀ¸·Î Á¡Â÷ È®»êµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á±â±â Á¦Á¶¾÷ü, ÀÇ·á º¸Çè»ç, µðÁöÅÐ Çコ Ç÷§ÆûÀº °¡Ä¡ ±â¹Ý ÄÉ¾î ¸ðµ¨¿¡ µû¶ó ±¸µ¶ ±â¹Ý ¼­ºñ½º ¹× ¿ø°Ý ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀ» °³¹ßÇϱâ À§ÇØ Çù·ÂÇϰí ÀÖ½À´Ï´Ù.

Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº ¹«¾ùÀΰ¡?

Áö´ÉÇü õ½Ä ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¼ºÀåÀº õ½Ä À¯º´·ü Áõ°¡, ¿¹¹æÀÇÇп¡ ´ëÇÑ °ü½É Áõ°¡, ¸¸¼ºÁúȯ °ü¸®¿¡¼­ µðÁöÅÐ Çコ ÅøÀÇ Ã¤Åà Ȯ´ë µî ¿©·¯ °¡Áö ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. ¼¾¼­ÀÇ ¼ÒÇüÈ­, ¹«¼± ¿¬°á, Ŭ¶ó¿ìµå ±â¹Ý ºÐ¼®ÀÇ ¹ßÀüÀ¸·Î ¿øÈ°ÇÑ È¯ÀÚ ¸ð´ÏÅ͸µ°ú °³º°È­µÈ °³ÀÔ Àü·«ÀÌ °¡´ÉÇØÁ³½À´Ï´Ù.

ÀçÅÃÀÇ·á, ¼Ò¾Æ õ½Ä ÇÁ·Î±×·¥, Áý´Ü °Ç°­ ÀÌ´Ï¼ÅÆ¼ºêÀÇ ÃÖÁ¾ ¿ëµµ È®´ë°¡ Áö¼ÓÀûÀÎ ¼ö¿ä¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ÇコÄÉ¾î ºñ¿ë ¾Ð¹Ú°ú °¡Ä¡ ±â¹Ý ¼º°ú¿¡ ´ëÇÑ ±ÔÁ¦ °­È­·Î ÀÎÇØ ÀÀ±Þ½Ç ¹æ¹®°ú ÀÔ¿øÀ» ÁÙÀ̱â À§ÇÑ µ¥ÀÌÅÍ ±â¹Ý µµ±¸ÀÇ µµÀÔÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. °¡»ó Äɾî Ç÷§Æû ¹× ¸ð¹ÙÀÏ Çコ ¿¡ÄڽýºÅÛ°úÀÇ ÅëÇÕÀ¸·Î Àå±âÀûÀΠȣÈí °ü¸®¿¡¼­ Áö´ÉÇü õ½Ä ±â±âÀÇ °ü·Ã¼ºÀÌ °­È­µÇ°í ÀÖ½À´Ï´Ù.

ºÎ¹®

µð¹ÙÀ̽º À¯Çü(¿þ¾î·¯ºí õ½Ä ¸ð´ÏÅ͸µ ±â±â, ½º¸¶Æ® ÈíÀÔ±â, ÈíÀÔ±â, °ÇÁ¶ ºÐ¸» ÈíÀÔ±â, Á¤·® ÈíÀÔ±â, ³×ºí¶óÀÌÀú), ÃÖÁ¾»ç¿ëÀÚ(º´¿ø ÃÖÁ¾»ç¿ëÀÚ, Ŭ¸®´Ð ÃÖÁ¾»ç¿ëÀÚ, Ȩ ÃÖÁ¾»ç¿ëÀÚ, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°èº° SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Intelligent Asthma Monitoring Devices Market to Reach US$2.8 Billion by 2030

The global market for Intelligent Asthma Monitoring Devices estimated at US$787.3 Million in the year 2024, is expected to reach US$2.8 Billion by 2030, growing at a CAGR of 23.7% over the analysis period 2024-2030. Wearable Asthma Monitoring Devices, one of the segments analyzed in the report, is expected to record a 20.2% CAGR and reach US$581.0 Million by the end of the analysis period. Growth in the Smart Inhalers segment is estimated at 26.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$214.5 Million While China is Forecast to Grow at 30.8% CAGR

The Intelligent Asthma Monitoring Devices market in the U.S. is estimated at US$214.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$663.3 Million by the year 2030 trailing a CAGR of 30.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 19.4% and 21.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 19.8% CAGR.

Global Intelligent Asthma Monitoring Devices Market - Key Trends & Drivers Summarized

How Are Intelligent Devices Changing Asthma Management for Patients and Providers?

Intelligent asthma monitoring devices are connected systems that track inhaler usage, monitor respiratory patterns, and provide real-time feedback to patients and clinicians. These devices include smart inhalers, wearable sensors, digital spirometers, and mobile health platforms that integrate medication reminders, symptom tracking, and environmental alerts. Their adoption is transforming asthma management from episodic care to continuous, data-driven monitoring.

Patients benefit from improved adherence, better symptom control, and timely interventions, while healthcare providers gain access to objective data on inhaler technique, usage frequency, and treatment response. Intelligent monitoring is especially valuable in reducing emergency room visits and preventing exacerbations, particularly in children, elderly patients, and those with poorly controlled asthma. These tools are enabling personalized care plans and improved long-term outcomes.

What Technologies and Features Are Driving Innovation in Monitoring Solutions?

Technological advances are central to the development of intelligent asthma devices. Bluetooth-enabled inhaler attachments and wearable respiratory monitors collect real-time usage data and transmit it to cloud-based platforms for analysis. Integration with mobile apps allows patients to view trends, receive reminders, and report symptoms. Some devices incorporate sensors that track environmental triggers such as pollen, temperature, and air quality to alert users about risk conditions.

Machine learning and predictive analytics are being used to forecast asthma attacks and identify adherence patterns. Pediatric models with gamified interfaces and family monitoring functions are helping improve engagement in younger patients. Voice-guided inhaler coaching, smart dosing systems, and multi-drug compatibility are being added to improve usability. Compatibility with electronic health records is also facilitating remote consultations and proactive adjustments to therapy.

Where Is Usage Expanding, and Which Stakeholders Are Leading Adoption?

Usage is expanding in hospitals, outpatient clinics, and home care settings. Patients with moderate to severe asthma, frequent hospitalizations, or inconsistent medication use are key users of intelligent monitoring. Primary care physicians, pulmonologists, and allergists are using data to make timely treatment decisions and reduce care variability. Pediatric asthma programs are integrating smart devices into school-based health initiatives.

Health systems in North America and Europe are leading in adoption due to reimbursement support, chronic disease management frameworks, and mHealth infrastructure. Asia Pacific markets are seeing gradual uptake, driven by urban populations, mobile connectivity, and increasing asthma prevalence. Device manufacturers, health insurers, and digital health platforms are partnering to develop subscription-based services and remote monitoring solutions that align with value-based care models.

What Is Driving Growth in the Intelligent Asthma Monitoring Devices Market?

Growth in the intelligent asthma monitoring devices market is driven by several factors including rising asthma prevalence, increasing emphasis on preventive care, and growing adoption of digital health tools in chronic disease management. Advancements in sensor miniaturization, wireless connectivity, and cloud-based analytics are enabling seamless patient monitoring and personalized intervention strategies.

End-use expansion in home-based care, pediatric asthma programs, and population health initiatives is supporting recurring demand. Healthcare cost pressures and regulatory push for value-based outcomes are encouraging adoption of data-driven tools that reduce emergency visits and hospitalizations. Integration with virtual care platforms and mobile health ecosystems is reinforcing the relevance of intelligent asthma devices in long-term respiratory care management.

SCOPE OF STUDY:

The report analyzes the Intelligent Asthma Monitoring Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Device Type (Wearable Asthma Monitoring Devices, Smart Inhalers, Inhalers, Dry Powdered Inhalers, Metered Dose Inhalers, Nebulizers); End-Use (Hospitals End-Use, Clinics End-Use, Home End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â